Jain, P., Romaguera, J., Nomie, K., Zhang, S., Wang, L., Oriabure, O., Wagner‐Bartak, N., Zhang, L., Hagemeister, F., Samaniego, F., Westin, J., Ju Lee, H., Nastoupil, L., Iyer, S., Parmar, S., Ok, C., Kanagal‐Shamanna, R., Chen, W., Thirumurthi, S., Santos, D., Badillo, M., Fayad, L., Neelapu, S., Fowler, N., & Wang, M. (n.d.). cOMBINATION OF IBRUTINIB WITH RITUXIMAB (IR) IS HIGHLY EFFECTIVE IN PREVIOUSLY UNTREATED ELDERLY (>65 YEARS) PATIENTS (PTS) WITH MANTLE CELL LYMPHOMA (MCL) – PHASE II TRIAL. Hematological oncology, 37, 42. http://access.bl.uk/ark:/81055/vdc_100086209591.0x00003f